Erin McEvoy

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the most surprising results and quality of treatment response he sees when treating his patients with medical cannabis and psychedelics.

On September 7th, 2022, the Cannabis Center of Excellence (CCOE), Undoo, LLC, and Patriots Helping Vets launched a new national research project for US military veterans to study the efficacy of three products that address the after-effects of cannabis usage.

In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the biggest challenge he encounters when educating other healthcare professionals on medical cannabis, both in the past and today.

Recently, some major food and beverage companies expressed interest in selling products containing cannabidiol (CBD), but the Food and Drug Administration (FDA) have not indicated any regulatory progress.

Cannabis Science Conference East was held in Baltimore, Maryland from September 14-16, 2022. Here we provide a few highlights from the event.

In a presentation for the psychedelics track at Cannabis Science Conference East 2022, Janie Maedler, Vice President of Rylie’s Smile Foundation and President of Rylie’s Sunshine LLC, led a panel discussion with Rylie Maedler, President of Rylie’s Smile and CEO of Rylie’s Sunshine LLC; Rita Lynn Lawrence, a cannabis patient advocate; and University of Miami cannabis epidemiologist Dr. Denise Vidot. The presentation titled “Psychedelics for Beginners” discussed the basics of using psychedelics for treating mental health issues safely and successfully. Here are some highlights from the session.

Dr. Dustin Sulak of Healer.com and Integr8 Health shares some insights from two talks he gave at Cannabis Science Conference East 2022.

In his presentation for the psychedelics track at Cannabis Science Conference East 2022, James Schwartz, BSN, LNC, presented “A New Beginning for an Old Therapy: Case Series Review on the Treatment of PTSD and Other Psychiatric Disorders with Psilocybin and Other Psychedelics.” He reviewed the current research and clinical trials studying the effects of psilocybin, plus side effects, potential uses, latest trends, disorders currently being studied, and potential future applications. Schwartz was a trauma trained nurse who worked in the Trauma/Critical Care ICU at Oregon Health and Science University. He is an experienced medical legal consultant and CEO of Cascade High. Here are some highlights from his session.

In his keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Matthew Johnson presented his talk “Psilocybin in the Treatment of Tobacco Addiction,” which reviewed the treatment of substance use disorders with classic psychedelics (5HT2A agonists) including LSD and psilocybin. Dr. Matthew Johnson, PhD, is the Susan Hill Ward Professor of Psychedelics at Johns Hopkins and is one of the world’s most widely published experts on psychedelics. Here are some highlights from his session.

In a keynote address for the psychedelics track at Cannabis Science Conference East 2022, Dr. Andrew Coop, Dr. Chad Johnson, and Dr. Leah Sera of the University of Maryland School of Pharmacy presented “There’S Room for Everyone: The Emerging Field of Psychedelic Therapeutics.” The talk focused on the history of psychedelics, “classical” and “nonclassical” psychedelics, the current clinical research studies on psychedelics, and the announcement of a master’s program in the Cannabis Science and Therapeutics program at the University of Maryland School of Pharmacy. Here are some highlights from the session.

Dr. Anthony Macherone of Agilent Technologies discusses some of the unique challenges when developing testing methods for cannabis products.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

Recently in France, 31 senators published a co-signed letter in the French newspaper “Le Monde,” calling for the launch of a consultation process to introduce new laws to legalize cannabis in France.

Dr. Elizabeth Hughes explains her unique perspectives on health, the influence of the subconscious, and incorporating CBD oil as part of treatments.

The National Institute on Drug Abuse (NIDA) recently posted a notice to Drug Enforcement Agency-approved cannabis manufacturers that they will soon be able to submit applications to supply cannabis for research purposes. Currently, NIDA has only worked with one cannabis farm for the past 50 years–the new cannabis supplier selected by NIDA would be the second federally authorized in the country.

In Part II of this interview, Jaqueline McGrane, Senior Vice President of Business Development at Boulder Creek Technologies (BCT) explains the importance of consumers being able to recognize the differences between acidic and neutral cannabinoids, especially when considering current product labelling practices.

Recently, Leaf411, the United States’ first cannabis nurse guidance call service, welcomed as its newest member Healer.com, a cannabis education and training resource founded by osteopathic physician, Dr. Dustin Sulak.

On July 11, 2022, the Cannabis Center of Excellence (CCOE), Gibby’s Garden, Patriots Helping Vets, Tetragram, and several retailers united to study veteran access to medical cannabis. The research study will reportedly request feedback from 450 veterans to gather their firsthand experiences with access, products, and the impact on health.

In part I of this interview, Jaqueline McGrane, Senior Vice President of Business Development at Boulder Creek Technologies, gives an in-depth description of the unique functionality of their extraction system and the advantages it provides to clients in terms of efficacy, quality, and safety.

Recently, Leafreport, an Israeli company that provides reviews and comparisons of cannabidiol (CBD) companies and products, released their 2022 report on their transparency analysis for 4384 CBD products.

Americans for Safe Access (ASA) is a non-profit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research. ASA was founded in 2002 by medical cannabis patient, Steph Sherer, as a vehicle for patients to advocate for the acceptance of cannabis as medicine. ASA has local chapters throughout the United States, and in this series of interviews, we introduce you to those chapters and highlight some of the state-level work being done to advocate for patients’ access and rights. In this installment, Nico Murillo, the chair of the Dallas, Texas chapter, shares some advocacy highlights from the lone star state.

In this interview, Donaghue Woodman, Head of Research and Development and Chief Medical Information Officer at Cannsun, provides an in-depth look at their current clinical trial on the effects of psilocybin in treating a prevalent yet unresolved issue in South Africa.

Cannabis Science Conference West was held in Long Beach, California from May 18–20, 2022. Here we provide a few highlights from the event.

Ellsworth Corporation, a global distributor of specialty chemicals and equipment, recently announced their acquisition of TapeCase Ltd., a distributor of adhesive tape products.

Colombian-based public health company, Khiron Life Sciences Corp., published the results of its first clinical study on the use of medical cannabis prescribed to patients in treating chronic pain.

Cannabis testing laboratories play an important role in ensuring consumer safety and quality throughout the industry. These laboratories face many challenges—from the variety of samples in the industry to changing regulations and testing requirements and everything in between. In this interview, Sarah Ahrens, Founder and CEO of True Labs for Cannabis LLC, explains her philosophy and approach behind building her cannabis analytical testing laboratory in New Jersey. She also covers current developments in the cannabis testing industry and what needs to be done to ensure it has a transparent and productive future that benefits producers and consumers alike.

On May 19, 2022 a federal appeals court ruled in a California vaping dispute that delta-8 tetrahydrocannabinol (THC) derived from hemp is “lawful.”

Thai Health Minister, Anutin Charnvirakul, announced in a May Facebook post that the Thai government will distribute 1,000,000 cannabis plants for medical purposes to households across the nation for free starting in June.

ASA has local chapters throughout the United States and in this new series of interviews, we will be introducing you to those chapters and highlighting some of the state-level work being done to advocate for patient’s access and rights. In our second installment, we introduce the San Diego ASA chapter.

CannMed held their 2022 medical practicum and science conference in Pasadena, California from May 3 – 5.